The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer-Reference-Cited by-同舟云学术

The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer

Published:2017-08-03 Issue:41 Volume:8 Page:70642-70652
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Chen Dong¹²³,Sun Qiang²³⁴,Zhang Lufei²³⁴,Zhou Xiaohu²³⁴,Cheng Xiaofei¹²³,Zhou Dongkai²³⁴,Ye Feng¹,Lin Jianjiang¹,Wang Weilin²³⁴

Affiliation:

1. Department of Colorectal Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

2. Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China

3. State Key Laboratory & Collaborative Innovation Center for Diagnosis and Treatment of Infectious Disease, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

4. Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HOXA11‐AS to mitigate prostate cancer via the glycolytic metabolism: In vitro and in vivo;Journal of Cellular and Molecular Medicine;2024-03-23

2. Hypoxia/inflammation-induced upregulation of HIF-1α and C/EBPβ promotes nephroblastoma cell EMT by improving HOXA11-AS transcription;Heliyon;2024-03

3. PAD2: A potential target for tumor therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-09

4. Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer;World Journal of Clinical Oncology;2023-08-24

5. A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer;BMC Medical Genomics;2023-06-19